Close Menu

NEW YORK – Sample preparation firm NuProbe today announced it has secured an exclusive global license to two oligonucleotide technologies from Rice University.

The technologies are non-extensible oligonucleotides (NEO) and linear DNA assembly (LDA.) NEO will lead to faster custom sequencing panel development while LDA technology will improve the throughput of nanopore-based sequencing by up to 10 times for short DNA, the firm said in a statement.

Financial and other details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.